Severe obesity, high inflammation, insulin resistance with risks of all-cause mortality and all-site cancers, and potential modification by healthy lifestyles

Severe obesity, high inflammation, insulin resistance with risks of all-cause mortality and all-site cancers, and potential modification by healthy lifestyles

Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71, 209–249 (2021). Article  MATH  Google Scholar  NCD Countdown. : worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet.392, 1072-88. (2018). Trends in adult. Body-mass…

Read More
Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to the ''Healthy China''

Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to the ”Healthy China”

SHANGHAI, Nov. 8, 2024 /PRNewswire/ — Illumina Hong Kong LIMITED (Illumina), a global leader in DNA sequencing and array-based technologies, and PHASE Scientific International Limited (PHASE), a Hong Kong-based biotech company with operations in the U.S. and the Greater Bay Area (GBA), signed a three-year Memorandum of Understanding (MoU) on 7 November at the 7th…

Read More
Post-treatment lifestyle choices influence long-term outcomes in breast cancer patients

Post-treatment lifestyle choices influence long-term outcomes in breast cancer patients

Three studies led by Dana-Farber Cancer Institute researchers have encouraging implications for patients with breast cancer. Two studies focus on breastfeeding after breast cancer diagnosis and treatment. The studies found it was safe and feasible for young patients carrying specific genetic variations to breastfeed without raising their risk of a cancer recurrence or a cancer…

Read More